Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma.Bart C. Kuenen, Adrian L. Harris, S. Seeber et al.|PubMed|2003Cited by 127
Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or MelanomaJeremy Braybrooke, Adrian L. Harris, Andrew Slade et al.|Clinical Cancer Research|2005Cited by 99
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinomaG. Deplanque, Adrian L. Harris, Andrew D. Blann et al.|British Journal of Cancer|2004Cited by 20